Article
Hematology
Hirotada Otsuka, Yasuo Endo, Hiroshi Ohtsu, Satoshi Inoue, Syunya Noguchi, Masanori Nakamura, Satoshi Soeta
Summary: Histamine may affect the hematopoietic microenvironments of the bone marrow and spleen by changing hematopoiesis-related factors in NBP-induced extramedullary hematopoiesis.
INTERNATIONAL JOURNAL OF HEMATOLOGY
(2021)
Article
Immunology
Yao Fu, Zhengjuan Li, Wen Lin, Jingxin Yao, Xiang Jiang, Qun Shu, Xiaoyuan Mao, Jiaoqin Tu, Xinyuan Liang, Liping Li
Summary: During pregnancy, there is an increase in red blood cells, particularly CD71(+) erythroid cells (CECs) which mainly undergo extramedullary hematopoiesis in the spleen. The expansion of CECs during pregnancy is primarily driven by splenic stromal cells through activation of TGF-beta signaling, while splenic macrophages contribute to extramedullary erythropoiesis in a TGF-beta-independent manner.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Immunology
Jiajie Li, Lin Liu, Junmin Xing, Dianhui Chen, Chao Fang, Feng Mo, Yumei Gong, Zhengrong Tan, Guikuan Liang, Wei Xiao, Shanni Tang, Haixia Wei, Shan Zhao, Hongyan Xie, Xingfei Pan, Xiaomao Yin, Jun Huang
Summary: Splenomegaly is a common symptom of malaria, but its causes are not fully understood. In this study, the researchers found that TLR7 played a role in promoting extramedullary splenic erythropoiesis in mice infected with Plasmodium yoelii NSM. They also found that TLR7 enhanced the production of IFN-? which promoted phagocytosis of infected erythrocytes and the iron metabolism of macrophages. Furthermore, neutralizing IFN-? partially inhibited extramedullary splenic erythropoiesis and reduced iron accumulation in the spleen. Overall, this study highlights the importance of TLR7 in regulating splenic erythropoiesis in malaria.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Immunology
Yasuhiro Umeyama, Hirokazu Taniguchi, Hiroshi Gyotoku, Hiroaki Senju, Hiromi Tomono, Shinnosuke Takemoto, Hiroyuki Yamaguchi, Mohammed S. O. Tagod, Masashi Iwasaki, Yoshimasa Tanaka, Hiroshi Mukae
Summary: Malignant pleural mesothelioma (MPM) is a rare and aggressive thoracic tumor with limited treatment options. Immune checkpoint inhibitors show promise in some patients, but the majority have only modest response rates. Developing innovative therapies, including immune effector cell-based therapies, is crucial for MPM.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Genetics & Heredity
Zijuan Xin, Wei Zhang, Shangjin Gong, Junwei Zhu, Yanming Li, Zhaojun Zhang, Xiangdong Fang
Summary: This study established a RBC regeneration system using iPSCs and used a single-cell transcriptome platform to map cell lineage and differentiation trajectory on day 14. The differentiation of iPSCs during embryoid body culture was found to be unsynchronized, with cells mainly consisting of mesodermal and various blood cells resembling yolk sac hematopoiesis. The study identified different stages of erythroid cells and regulatory transcription factors specific to each stage, providing theoretical guidance for optimizing iPSC-derived erythroid differentiation system.
GENOMICS PROTEOMICS & BIOINFORMATICS
(2021)
Article
Microscopy
Yoshitoki Takagi, Satoshi Inoue, Kaoru Fujikawa, Miwako Matsuki-Fukushima, Mitsuori Mayahara, Kayo Matsuyama, Yasuo Endo, Masanori Nakamura
Summary: The study found that alendronate affects mouse osteoclasts by altering cell structure and inducing fusion of osteoclasts to form giant cells.
Article
Cell Biology
Riyoko Tamai, Izumi Mashima, Yusuke Kiyoura
Summary: The study found that alendronate enhances lipid A-induced IL-1α release independently of caspase-8 and is associated with NLRP3 and ASC.
Review
Cell Biology
Gengchen Wang, Qian Zhou, Yan Xu, Baobing Zhao
Summary: Pleckstrin-2, a member of the pleckstrin family, has well-defined structural features and has been studied for 20 years. Recent evidence suggests it plays important roles in erythropoiesis, tumorigenesis, and metastasis, making it a potential diagnostic and prognostic biomarker and treatment target for cancers.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Review
Genetics & Heredity
Mark C. Wilkes, Aya Shibuya, Kathleen M. Sakamoto
Summary: Blood cell development is regulated through intrinsic gene regulation and local factors, with signaling pathways involving various kinases. Many cytokines are synthesized and regulated by these pathways, which act both upstream and downstream of the erythropoiesis process. There is still much to be discovered about the nuanced network of kinases responsible for appropriate induction of, and response to, these cytokines.
Article
Cell Biology
Annamaria Aprile, Laura Raggi, Simona Bolamperti, Isabella Villa, Mariangela Storto, Gaia Morello, Sarah Marktel, Claudio Tripodo, Maria Domenica Cappellini, Irene Motta, Alessandro Rubinacci, Giuliana Ferrari
Summary: Clinical evidence suggests a relationship between blood and bone, but the underlying mechanism is not fully understood. A study using beta-thalassemia as a model found that increased fibroblast growth factor 23 (FGF23) levels in patients and mice with beta-thalassemia were induced by erythropoietin via ERK1/2 and STAT5 pathways. Inhibiting FGF23 signaling with carboxyl-terminal FGF23 peptide rescued bone defects and restored hematopoietic stem cell function in mice with beta-thalassemia. FGF23 may serve as a molecular link connecting anemia, bone, and the hematopoietic stem cell niche.
SCIENCE TRANSLATIONAL MEDICINE
(2023)
Article
Cell Biology
Annamaria Aprile, Laura Raggi, Simona Bolamperti, Isabella Villa, Mariangela Storto, Gaia Morello, Sarah Marktel, Claudio Tripodo, Maria Domenica Cappellini, Irene Motta, Alessandro Rubinacci, Giuliana Ferrari
Summary: This study demonstrates the overproduction of fibroblast growth factor 23 (FGF23) in patients and mice with beta-thalassemia, and shows that inhibition of FGF23 signaling is a safe and effective therapeutic strategy to rescue bone defects and restore hematopoietic stem cell function. FGF23 may serve as a molecular link connecting anemia, bone, and the HSC niche.
SCIENCE TRANSLATIONAL MEDICINE
(2023)
Article
Immunology
Fang Zheng, Jinhong Zhou, Zhenlin Ouyang, Jiaxin Zhang, Xinyi Wang, Serge Muyldermans, Jo Van Ginderachter, Nick Devoogdt, Yurong Wen, Steve Schoonooghe, Geert Raes
Summary: Nanobodies derived from camelids have been developed targeting the Kupffer cell-specific receptor Clec4F, with a strong affinity and the ability to specifically target the liver. Structural characterization revealed distinct features within the CDR2 and CDR3 regions of the nanobodies, indicating different recognition epitopes.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Endocrinology & Metabolism
R. H. Lee, J. Curtis, M. T. Drake, S. Bobo Tanner, L. Lenert, K. Schmader, C. Pieper, R. North, K. W. Lyles
Summary: In this retrospective longitudinal study, no benefit of nitrogen-containing bisphosphonates (N-BP) was found regarding ICU admission, ventilator use, and mortality among older adults with COVID-19 infection. Specifically, the intravenous bisphosphonate zoledronic acid (ZOL) was evaluated and no difference was found compared to oral bisphosphonates.
OSTEOPOROSIS INTERNATIONAL
(2023)
Article
Cell & Tissue Engineering
Pal Boto, Timea Beatrix Gerzsenyi, Adel Lengyel, Balint Szunyog, Istvan Szatmari
Summary: Zbtb46 suppresses myeloid development and diverts mesoderm cells toward erythroid developmental pathway in ESC-derived progenitors. Despite repressive effects, Zbtb46 overexpression enhances erythroid blood cell colony formation and increases adult hemoglobin expression, along with an elevated percentage of CD105 positive cells.
Article
Endocrinology & Metabolism
Kanan Bando, Toshinobu Kuroishi, Hiroyuki Tada, Takefumi Oizumi, Yukinori Tanaka, Tetsu Takahashi, Itaru Mizoguchi, Shunji Sugawara, Yasuo Endo
Summary: N-BPs induce both early-phase and late-phase inflammation via ATP production and P2X7 receptor stimulation. Both N-BPs and LPS mutually augment responses in both early and late phases through ATP-mediated IL-1 beta production by neutrophils, macrophages, and dendritic cells. NET production by IL-1 beta-stimulated neutrophils may mediate the late phase, leading to prolonged inflammation.
JOURNAL OF BONE AND MINERAL RESEARCH
(2021)
Article
Cell Biology
Hirotada Otsuka, Hideki Yagi, Yasuo Endo, Satoshi Soeta, Naoko Nonaka, Masanori Nakamura
CELL AND TISSUE RESEARCH
(2017)
Article
Immunology
Shiki Takamura, Hideki Yagi, Yoshiyuki Hakata, Chihiro Motozono, Sean R. McMaster, Tomoko Masumoto, Makoto Fujisawa, Tomomi Chikaishi, Junko Komeda, Jun Itoh, Miki Umemura, Ami Kyusai, Michio Tomura, Toshinori Nakayama, David L. Woodland, Jacob E. Kohlmeier, Masaaki Miyazawa
JOURNAL OF EXPERIMENTAL MEDICINE
(2016)
Article
Chemistry, Organic
Yoshihiro Suyama, Yusuke Higashino, Naonobu Tanaka, Yutaka Tatano, Hideki Yagi, Kazuyoshi Kawazoe, Kotaro Murakami, Shun-Lin Li, Han-Dong Sun, Yoshiki Kashiwada
TETRAHEDRON LETTERS
(2017)
Article
Oncology
Miyuki Ookura, Tatsuya Fujii, Hideki Yagi, Takuya Ogawa, Shinji Kishi, Naoko Hosono, Hiroko Shigemi, Takahiro Yamauchi, Takanori Ueda, Akira Yoshida
Article
Chemistry, Organic
Naonobu Tanaka, Yuyu Jia, Kanji Niwa, Kiyoshi Imabayashi, Yutaka Tatano, Hideki Yagi, Yoshiki Kashiwada
Article
Oncology
Takatsugu Ishimoto, Osamu Nagano, Toshifumi Yae, Mayumi Tamada, Takeshi Motohara, Hiroko Oshima, Masanobu Oshima, Tatsuya Ikeda, Rika Asaba, Hideki Yagi, Takashi Masuko, Takatsune Shimizu, Tomoki Ishikawa, Kazuharu Kai, Eri Takahashi, Yu Imamura, Yoshifumi Baba, Mitsuyo Ohmura, Makoto Suematsu, Hideo Baba, Hideyuki Saya
Article
Oncology
Kaori Hara, Shiho Ueda, Yoshiya Ohno, Toshiyuki Tanaka, Hideki Yagi, Shogo Okazaki, Rieko Kawahara, Takechi Masayuki, Takemi Enomoto, Yoshiyuki Hashimoto, Kazue Masuko, Takashi Masuko
Article
Oncology
Yuta Hara, Ryota Torii, Shiho Ueda, Erina Kurimoto, Eri Ueda, Hiroshi Okura, Yutaka Tatano, Hideki Yagi, Yoshiya Ohno, Toshiyuki Tanaka, Kazue Masuko, Takashi Masuko
Article
Cell Biology
Mayumi Hidaka, Masanori Nakamura, Yukari Ohmichi, Jun Itoh, Kenji Fukuzawa, Takashi Masuko, Hideki Yagi
CELLULAR IMMUNOLOGY
(2012)
Article
Immunology
Yasuhiro Maeda, Hideki Yagi, Kana Takemoto, Hiroyuki Utsumi, Atsushi Fukunari, Kunio Sugahara, Takashi Masuko, Kenji Chiba
INTERNATIONAL IMMUNOLOGY
(2014)
Article
Infectious Diseases
Yoshio Takesue, Takashi Ueda, Hiroshige Mikamo, Shigeto Oda, Shunji Takakura, Yuko Kitagawa, Shigeru Kohno
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2015)
Article
Pharmacology & Pharmacy
Masayuki Takechi, Tetsuyuki Wada, Hideki Yagi, Takashi Masuko, Atsufumi Kawabata
JOURNAL OF PHARMACY AND PHARMACOLOGY
(2015)
Article
Multidisciplinary Sciences
Kazue Masuko, Shogo Okazaki, Mayumi Satoh, Goh Tanaka, Tatsuya Ikeda, Ryota Torii, Eri Ueda, Takashi Nakano, Masaaki Danbayashi, Tomoyo Tsuruoka, Yoshiya Ohno, Hideki Yagi, Noritsugu Yabe, Hideaki Yoshida, Tomoyuki Tahara, Shiro Kataoka, Taichi Oshino, Takayuki Shindo, Shin-ichiro Niwa, Takatsugu Ishimoto, Hideo Baba, Yoshiyuki Hashimoto, Hideyuki Saya, Takashi Masuko
Review
Pharmacology & Pharmacy
Hideki Yagi, Takashi Masuko
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
(2013)
Review
Pharmacology & Pharmacy
Keiji Nishiwaki, Atsushi Kawase, Tetsuyuki Wada, Hideki Yagi, Naohito Kawasaki, Eiji Ito, Masahiro Iwaki
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
(2014)
Article
Cell Biology
Jeffrey Maslanka, Gretel Torres, Jennifer Londregan, Naomi Goldman, Daniel Silberman, John Somerville, James E. Riggs
Summary: This study investigates the immunobiology of the peritoneum in ovarian cancer, revealing reduced B1 cells in the ascites and selective loss of B1 and marginal zone B cell subsets in the spleen. These findings suggest a correlation between the depletion of B cell subsets and the influx of myeloid-derived suppressor cells during ovarian cancer.
CELLULAR IMMUNOLOGY
(2024)